Chinese Journal of Tissue Engineering Research ›› 2011, Vol. 15 ›› Issue (19): 3433-3437.doi: 10.3969/j.issn.1673-8225.2011.19.003

Previous Articles     Next Articles

Construction of human LIM mineralization protein-1 gene recombinant adenovirus and its expression in dog bone marrow mesenchymal stem cells

Pu Chao, Ni Wei-dong, Gao Shi-chang, Qiu Yu   

  1. Department of Orthopedics, First Hospital Affiliated to Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing  400016, China
  • Received:2011-02-14 Revised:2011-03-20 Online:2011-05-07 Published:2011-05-07
  • Contact: Ni Wei-dong, Chief physician, Department of Orthopedics, First Hospital Affiliated to Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing 400016, China niweidong18@163.com
  • About author:Pu Chao★, Studying for master’s degree, Department of Orthopedics, First Hospital Affiliated to Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing 400016, China puchao3310@sina.com
  • Supported by:

    Medical Science and Technology Plan of Chongqing City*

Abstract:

BACKGROUND: Studies shows that the LIM mineralization protein 1 (LMP-1) can stimulate bone formation in vivo and in vitro.
OBJECTIVE: To construct the recombinant adenovirus vector containing LMP-1 gene by using the Ad-Easy system, then to detect the gene expression and study the mechanism of bone formation induced by LMP-1 in infected dog bone marrow mesenchymal stem cells (BMSCs).
METHODS: The recombinant plasmid pAd-LMP-1 was constructed. The replication-defective recombinant adenovirus Ad-LMP-1 was packaged and amplified in the human embryonic kidney 293 cells (HEK293). Dog BMSCs were infected by Ad-LMP-1 in the best value of MOI in vitro. The gene expression of LMP-1and BMP-7 was detected by RT-PCR and Western Blot. Dogs BMSCs were treated with Ad-LMP-1 and recombinant human bone morphogenetic protein 7 (rhBMP-7) to study the mechanism of bone formation of LMP-1 undergoing mineralization (Ca) nodules at 21 days by alizarin red staining.
RESULTS AND CONCLUSION: ①Ad-LMP-1 was successfully constructed and obtained titers in the packaging about 1×1011 efu/mL after amplified in HEK293. ②The best efficiency could be obtained at the most appropriate MOI 100 after Ad-LMP-1 infected BMSCs. Infected BMSCs can express mRNA and protein of LMP-1, but not caused expression of BMP-7. ③ Dog BMSCs were treated with Ad-LMP-1 and (or) rhBMP-7 for 21 days. We found that Ad-LMP-1 with exogenous rhBMP-7 promote transformation into osteoblasts together. Neither Ad-LMP-1 nor rhBMP-7 alone induced any transformation on day 21. The recombinant adenoviral vector containing hLMP-1 gene was successfully constructed and expressed effectively in dogs BMSCs. It is confirmed that the mechanism of bone formation induced by LMP-1 is synergistic effect with the performance of exogenous rhBMP-7.

CLC Number: